Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta2-agonists and exercise-induced asthma.

Sandra D Anderson1, Corinne Caillaud, John D Brannan

  • 1Department of Respiratory Medicine, Royal Prince Alfred Hospital, Camperdown, Australia. sandya@med.usyd.edu.au

Clinical Reviews in Allergy & Immunology
|November 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Branched-Chain Amino Acid Supplementation Alone or Combined With Tryptophan or Methionine on Appetite Control and Related Health Outcomes in Older Adults: Protocol for a Randomized Controlled Trial.

JMIR research protocols·2026
Same author

Modeling the effects of flight itinerary on jetlag duration.

Sleep·2026
Same author

Food cultures, lifestyles and health of Pacific adolescents: Questionnaire data and anthropometric measurements focused on 11 to 16 years old students living in New Caledonia.

Data in brief·2025
Same author

Personalising the management of obesity-related asthma using medical nutrition therapy and physical activity prescription: The IDEAL study protocol.

Contemporary clinical trials·2025
Same author

Poor diagnostic performance of flow volume loops for detection of inducible laryngeal obstruction/vocal cord dysfunction.

The journal of allergy and clinical immunology. In practice·2025
Same author

Exploring the Digital Health Landscape: How adolescents living in urban and rural Vanuatu use online platforms to access health information.

Open research Europe·2025
Same journal

Therapeutic Targeting of the Bradykinin B2 Receptor in Immunological and Vascular Diseases: Insights from Kinin Biology to Clinical Outcomes.

Clinical reviews in allergy & immunology·2026
Same journal

β-blocker Therapy in Cholinergic Urticaria, Adrenergic Urticaria and the Aquagenic Continuum Beta-Blocker Therapy in Chronic Inducible Urticaria.

Clinical reviews in allergy & immunology·2026
Same journal

Immunopathogenesis and Cytokine Pathways in Reactive Infectious Mucocutaneous Eruption (RIME) in Pediatric Population: Infectious Triggers and Molecular Insights.

Clinical reviews in allergy & immunology·2026
Same journal

Neuropsychological Factors in Vitiligo: Mechanisms and Clinical Application.

Clinical reviews in allergy & immunology·2026
Same journal

Tertiary Lymphoid Structure: A Potential Therapeutic Target Affecting Immune Response in Autoimmune Diseases.

Clinical reviews in allergy & immunology·2026
Same journal

Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and Score Development.

Clinical reviews in allergy & immunology·2026
See all related articles

Daily use of beta2-agonists for exercise-induced asthma (EIA) may reduce their effectiveness and delay recovery. Physicians should consider alternative treatment regimens for better EIA control.

Area of Science:

  • Pulmonology
  • Pharmacology

Background:

  • Beta2-agonists are commonly used for exercise-induced asthma (EIA) prevention.
  • Daily use may lead to diminished protective effects and slower recovery from EIA.

Purpose of the Study:

  • To investigate the potential negative impacts of daily beta2-agonist use on EIA management.
  • To explore the clinical implications of beta2-receptor desensitization.

Main Methods:

  • Review of existing literature on beta2-agonist use in EIA.
  • Analysis of clinical observations regarding daily versus intermittent use.

Main Results:

  • A significant percentage of asthmatics experience inadequate EIA protection with beta2-agonists, even with concurrent inhaled corticosteroids.

Related Experiment Videos

  • Daily use can decrease the duration of protection and impair lung function recovery after EIA.
  • Beta2-receptor desensitization is a likely mechanism for these adverse effects.

    • Conclusions:

    • Daily beta2-agonist use may compromise their efficacy for EIA prevention and recovery.
    • Optimizing anti-inflammatory therapy is crucial for effective intermittent use of beta2-agonists.
    • Physicians should reassess treatment regimens for patients experiencing persistent EIA issues despite daily beta2-agonist use.